Stay updated on Trivalent P2-VP8 Vaccine Clinical Trial
Sign up to get notified when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.

Latest updates to the Trivalent P2-VP8 Vaccine Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Gauteng as a location under the Locations section. Removed the prior Gauteng Locations entry and the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.SummaryDifference0.2%

- Check59 days agoChange DetectedThe Publications section now states entries are automatically filled from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2. The deletions explain that PubMed-based publications are auto-generated by ClinicalTrials.gov using the NCT number, replacing the prior wording that referenced v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange Detected- Removed the government funding status notice banner. The page now shows only the study details and related information without that banner.SummaryDifference0.3%

- Check80 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and structure appear unchanged.SummaryDifference0.4%

- Check109 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a new version tag v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%

Stay in the know with updates to Trivalent P2-VP8 Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.